MedSearchGraphRAG
6 quiz questions available for this topicTake Quiz

Prostatitis - chronic

SNOMED: 19905009903 words•Updated 03/03/2026
💡

Exam Tips

  • Key discriminator: chronic prostatitis usually has no systemic sepsis features; fever/rigors with urinary symptoms suggests acute bacterial prostatitis.
  • For OSCEs, explicitly mention symptom duration >=3 months, pain location mapping, sexual symptoms, psychosocial screening, and validated tools (NIH-CPSI, IPSS).
  • In viva, avoid routine prostatic massage in primary care and justify tests: urine culture, STI NAAT, selective PSA after counselling.
  • Management marks are gained by phenotype-based multimodal care (pain, LUTS, psychological, sexual) rather than repeated empirical antibiotics in culture-negative disease.
  • Image cue for revision: see a male pelvic pain referral map and NIH-CPSI domain diagram in your urology textbook/lecture slides to link anatomy with symptom patterns.

Definition

Chronic prostatitis is a syndrome of persistent or recurrent urogenital/pelvic pain for at least 3 months, typically felt in the perineum, suprapubic area, genitalia, groin, rectum, or lower back, often with lower urinary tract and sexual symptoms. It includes chronic bacterial prostatitis (proven/recurrent infection) and, more commonly, chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), where no consistent bacterial cause is identified.

Pathophysiology

CP/CPPS is usually multifactorial rather than a single-organ infection: proposed mechanisms include an initial inflammatory or infective trigger, pelvic floor muscle overactivity, neuroimmune dysregulation, and peripheral then central pain sensitization (neuropathic-like pain amplification). Psychosocial stress, anxiety/depression, and autonomic-endocrine factors may perpetuate symptom flares, which explains why pain severity may not correlate with microbiology. In chronic bacterial prostatitis, recurrent ascending urethral infection or prostatic reflux seeds organisms (commonly Gram-negative bacilli such as E. coli), with bacterial persistence in prostatic tissue/biofilm leading to relapsing UTI-type episodes and chronic pain.

Risk Factors

  • Previous acute bacterial prostatitis or recurrent/relapsing UTI
  • Age 35-50 years (symptoms can occur at any age, with risk increasing with age)
  • Prior pelvic infection
  • Pelvic floor dysfunction or chronic pelvic muscle tension
  • Psychological comorbidity (anxiety, depression, stress-related symptom amplification)
  • Irritable bowel syndrome (associated with greater pain burden)
  • Immunocompromise/HIV (risk of atypical/fungal/mycobacterial prostate infection)
  • Sexual risk factors: multiple partners, recent partner change, STI exposure

Clinical Features

Symptoms

  • Pelvic/urogenital pain for at least 3 months (perineal pain is commonest)
  • Suprapubic, inguinal, penile tip, testicular/scrotal, rectal, lower back, or abdominal pain
  • Voiding LUTS: hesitancy, weak stream, straining
  • Storage LUTS: frequency, urgency, nocturia
  • Dysuria
  • Pain during or after ejaculation, erectile dysfunction, reduced libido, possible premature ejaculation
  • Haematospermia
  • Psychological impact: low mood, anxiety, reduced quality of life

Signs

  • Often no systemic illness (helps distinguish from acute bacterial prostatitis)
  • DRE: prostate may be normal, mildly enlarged, or tender
  • Localized perineal/suprapubic tenderness may be present
  • Possible pelvic floor tenderness/spasm on examination
  • If retention coexists, palpable bladder may be present

Investigations

Urine dipstick (blood, leucocytes, nitrite, glucose, protein):May be normal in CP/CPPS; pyuria/nitrite supports UTI and possible bacterial phenotype
Mid-stream urine culture and sensitivity (plus review prior cultures):Recurrent growth of uropathogens supports chronic bacterial prostatitis; single negative culture does not exclude it
STI testing (first-pass urine NAAT for chlamydia/gonorrhoea; consider trichomonas testing):Identifies sexually transmitted causes/coinfection, especially in younger or higher-risk men
NIH-CPSI symptom score:Quantifies pain, urinary symptoms, and quality-of-life impact; useful baseline for monitoring response
IPSS (if significant LUTS):Grades urinary symptom burden and guides adjunctive LUTS treatment
PSA (shared decision-making, non-acute setting):Used when cancer concern exists; interpret cautiously as prostatitis/inflammation can transiently raise PSA
Targeted additional tests if red flags/alternative diagnosis suspected (e. g, renal profile, imaging, cystoscopy via specialist):Usually to exclude obstruction, stones, malignancy, abscess, or other pelvic pathology rather than confirm CP/CPPS

Management

Lifestyle Modifications

  • Validate chronic pain impact; explain waxing/waning course and set realistic goals (symptom control, function, quality of life)
  • Avoid prolonged sitting/cycling if these trigger pain; use paced activity and pelvic floor relaxation strategies
  • Limit bladder irritants if LUTS prominent (caffeine, alcohol) and optimize hydration
  • Offer psychological support for anxiety/depression and pain-coping strategies
  • Avoid long-term opioids where possible due to dependence/medication-overuse risk

Pharmacological Treatment

Antibacterial therapy (when chronic bacterial prostatitis likely or culture-proven)

  • Ciprofloxacin 500 mg orally twice daily for 28 days
  • Ofloxacin 200 mg orally twice daily for 28 days
  • Levofloxacin 500 mg orally once daily for 28 days
  • Co-trimoxazole 960 mg orally twice daily for 28 days (if susceptible/appropriate)

Base choice on culture, local resistance, and prior antibiotic exposure. Fluoroquinolones: counsel on serious adverse effects (tendon injury, peripheral neuropathy, CNS effects, dysglycaemia, QT risk, aortic aneurysm warning); avoid with previous quinolone serious reaction and use caution in older adults, renal impairment, steroid co-use, or aneurysm risk.

Alpha-blockers for troublesome LUTS/voiding symptoms

  • Tamsulosin 400 micrograms orally once daily
  • Alfuzosin modified-release 10 mg orally once daily

Useful for flow symptoms and may help selected CP/CPPS patients. Warn about postural hypotension/dizziness; tamsulosin can cause ejaculatory dysfunction. Consider cataract surgery history (intraoperative floppy iris syndrome risk).

Analgesia/anti-inflammatory treatment

  • Paracetamol 1 g orally up to four times daily (max 4 g/day)
  • Ibuprofen 400 mg orally three times daily with food (lowest effective dose, shortest duration)
  • Naproxen 250-500 mg orally twice daily

Check GI, renal, and cardiovascular risk before NSAIDs; consider gastroprotection where indicated. Avoid chronic opioid escalation for non-cancer pelvic pain.

Neuropathic pain-modulating options (specialist/shared-care context, often off-label for CP/CPPS)

  • Amitriptyline 10 mg at night, titrate gradually
  • Gabapentin 100-300 mg at night then titrate to response/tolerability

Consider when neuropathic pain phenotype is prominent and first-line measures fail. Counsel regarding sedation, anticholinergic effects (amitriptyline), dizziness/dependence potential (gabapentinoids), and driving safety.

Surgical / Interventional

  • No routine surgery for CP/CPPS
  • Treat structural complications when present (e. g, drainage of prostatic abscess, management of bladder outlet obstruction) under urology

Complications

  • Chronic pain-related quality-of-life reduction (work, social, and sexual functioning)
  • Depression, anxiety, panic symptoms, and maladaptive illness behaviours
  • Medication harms, especially opioid dependence/overuse if long-term opioids are used
  • Persistent or recurrent LUTS and sexual dysfunction
  • After chronic bacterial prostatitis, some patients develop chronic pelvic pain syndrome despite bacterial eradication

Prognosis

Course is variable and often relapsing-remitting. In CP/CPPS, symptom response to treatment is heterogeneous and spontaneous improvement can occur, but a substantial proportion have persistent symptoms over years. In chronic bacterial prostatitis, prolonged targeted antibiotics can achieve microbiological cure in many patients, yet symptom resolution is not guaranteed and recurrence/chronic pain transition may occur.

Sources & References

✅NICE Guidelines(1)

📖Textbook References(16)

  • David Randall PhD MRCP (Editor), John Booth PhD MRCP (Editor), K - Kumar and Clark's Clinical Medicine (2025, American Elsevier Publishing Co.) - libgen.li.pdf(pp. 1720)[context]
  • David Randall PhD MRCP (Editor), John Booth PhD MRCP (Editor), K - Kumar and Clark's Clinical Medicine (2025, American Elsevier Publishing Co.) - libgen.li.pdf(pp. 1720)[context]
  • David Randall PhD MRCP (Editor), John Booth PhD MRCP (Editor), K - Kumar and Clark's Clinical Medicine (2025, American Elsevier Publishing Co.) - libgen.li.pdf(pp. 1827, 1828)[context]
  • David Randall PhD MRCP (Editor), John Booth PhD MRCP (Editor), K - Kumar and Clark's Clinical Medicine (2025, American Elsevier Publishing Co.) - libgen.li.pdf(pp. 1827)[context]
  • David Randall PhD MRCP (Editor), John Booth PhD MRCP (Editor), K - Kumar and Clark's Clinical Medicine (2025, American Elsevier Publishing Co.) - libgen.li.pdf(pp. 1719, 1720)[context]
  • [Oxford Medical Handbooks] Ian Wilkinson, Tim Raine, Kate Wiles, Anna Goodhart, Catriona Ha - Oxford Handbook of Clinical Medicine (2017, Oxford University Press) - libgen.li.pdf(pp. 660, 661)[context]
  • [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 1373, 1374)[context]
  • [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 1373)[context]
  • [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 1374)[context]
  • [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 1367, 1368)[context]
  • [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 1375)[context]
  • [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 1374, 1375)[context]
  • [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 1374)[context]
  • [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 1289)[context]
  • [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 1367, 1368)[context]
  • [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 1374)[context]

Sources

Test Your Knowledge

6 quiz questions available for this topic

Start Quiz